Gerresheimer AG (GXI.DE)
EUR 51.85
(2.07%)
EUR 51.85
(2.07%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 597.31 Million EUR | 9.24% |
| 2022 | 546.81 Million EUR | 23.65% |
| 2021 | 442.22 Million EUR | 1.06% |
| 2020 | 437.6 Million EUR | 57.87% |
| 2019 | 277.18 Million EUR | -30.73% |
| 2018 | 400.13 Million EUR | -3.31% |
| 2017 | 413.84 Million EUR | -4.15% |
| 2016 | 431.74 Million EUR | 6.61% |
| 2015 | 404.99 Million EUR | 13.72% |
| 2014 | 356.12 Million EUR | -2.22% |
| 2013 | 364.22 Million EUR | 1.9% |
| 2012 | 357.43 Million EUR | 11.3% |
| 2011 | 321.14 Million EUR | 5.02% |
| 2010 | 305.78 Million EUR | 15.28% |
| 2009 | 265.26 Million EUR | -9.55% |
| 2008 | 293.26 Million EUR | 6.95% |
| 2007 | 274.2 Million EUR | -42.17% |
| 2006 | 474.14 Million EUR | 25.98% |
| 2005 | 376.37 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 129.59 Million EUR | -18.66% |
| 2024 Q2 | 148.65 Million EUR | 14.71% |
| 2024 Q3 | 147.83 Million EUR | -0.55% |
| 2023 Q3 | 149.83 Million EUR | -2.78% |
| 2023 Q4 | 159.31 Million EUR | 6.33% |
| 2023 FY | 597.31 Million EUR | 9.24% |
| 2023 Q1 | 134.05 Million EUR | -16.17% |
| 2023 Q2 | 154.11 Million EUR | 14.97% |
| 2022 Q3 | 148.79 Million EUR | 8.34% |
| 2022 Q4 | 159.91 Million EUR | 7.48% |
| 2022 FY | 546.81 Million EUR | 23.65% |
| 2022 Q2 | 137.33 Million EUR | 36.29% |
| 2022 Q1 | 100.76 Million EUR | -21.92% |
| 2021 Q2 | 118.15 Million EUR | 46.39% |
| 2021 Q4 | 129.05 Million EUR | 12.9% |
| 2021 FY | 442.22 Million EUR | 1.06% |
| 2021 Q1 | 80.71 Million EUR | -39.62% |
| 2021 Q3 | 114.3 Million EUR | -3.26% |
| 2020 Q1 | 79.65 Million EUR | 1067.01% |
| 2020 FY | 437.6 Million EUR | 57.87% |
| 2020 Q4 | 133.68 Million EUR | 29.26% |
| 2020 Q3 | 103.42 Million EUR | -14.42% |
| 2020 Q2 | 120.85 Million EUR | 51.72% |
| 2019 Q4 | -8.23 Million EUR | -108.38% |
| 2019 Q3 | 98.24 Million EUR | -5.74% |
| 2019 Q2 | 104.22 Million EUR | 25.63% |
| 2019 Q1 | 82.96 Million EUR | -33.0% |
| 2019 FY | 277.18 Million EUR | -30.73% |
| 2018 Q1 | 81.11 Million EUR | -33.7% |
| 2018 FY | 400.13 Million EUR | -3.31% |
| 2018 Q3 | 97.86 Million EUR | 0.55% |
| 2018 Q2 | 97.33 Million EUR | 19.99% |
| 2018 Q4 | 123.82 Million EUR | 26.52% |
| 2017 Q1 | 88.44 Million EUR | -2.16% |
| 2017 Q3 | 99.02 Million EUR | -4.8% |
| 2017 Q4 | 122.34 Million EUR | 23.55% |
| 2017 Q2 | 104.02 Million EUR | 17.61% |
| 2017 FY | 413.84 Million EUR | -4.15% |
| 2016 Q3 | 120.5 Million EUR | 0.05% |
| 2016 Q2 | 120.43 Million EUR | 19.95% |
| 2016 Q4 | 90.39 Million EUR | -24.98% |
| 2016 FY | 431.74 Million EUR | 6.61% |
| 2016 Q1 | 100.4 Million EUR | -15.33% |
| 2015 Q4 | 118.58 Million EUR | 15.09% |
| 2015 Q1 | 77.35 Million EUR | -20.05% |
| 2015 Q3 | 103.03 Million EUR | -2.82% |
| 2015 FY | 404.99 Million EUR | 13.72% |
| 2015 Q2 | 106.02 Million EUR | 37.07% |
| 2014 Q1 | 74.53 Million EUR | -27.03% |
| 2014 FY | 356.12 Million EUR | -2.22% |
| 2014 Q4 | 96.75 Million EUR | 5.19% |
| 2014 Q3 | 91.97 Million EUR | -0.94% |
| 2014 Q2 | 92.85 Million EUR | 24.57% |
| 2013 FY | 364.22 Million EUR | 1.9% |
| 2013 Q1 | 75.74 Million EUR | -25.73% |
| 2013 Q2 | 96.07 Million EUR | 26.84% |
| 2013 Q4 | 102.14 Million EUR | 13.17% |
| 2013 Q3 | 90.25 Million EUR | -6.06% |
| 2012 Q4 | 101.98 Million EUR | 12.68% |
| 2012 Q1 | 74.62 Million EUR | -13.88% |
| 2012 FY | 357.43 Million EUR | 11.3% |
| 2012 Q2 | 90.3 Million EUR | 21.01% |
| 2012 Q3 | 90.51 Million EUR | 0.23% |
| 2011 Q2 | 85.2 Million EUR | 28.24% |
| 2011 Q1 | 66.44 Million EUR | -19.24% |
| 2011 Q3 | 82.84 Million EUR | -2.78% |
| 2011 Q4 | 86.65 Million EUR | 4.6% |
| 2011 FY | 321.14 Million EUR | 5.02% |
| 2010 Q3 | 83.67 Million EUR | 6.38% |
| 2010 Q1 | 61.17 Million EUR | -16.9% |
| 2010 Q4 | 82.27 Million EUR | -1.67% |
| 2010 Q2 | 78.65 Million EUR | 28.57% |
| 2010 FY | 305.78 Million EUR | 15.28% |
| 2009 Q2 | 72.02 Million EUR | 20.99% |
| 2009 FY | 265.26 Million EUR | -9.55% |
| 2009 Q1 | 59.52 Million EUR | 0.0% |
| 2009 Q3 | 60.09 Million EUR | -16.56% |
| 2009 Q4 | 73.62 Million EUR | 22.52% |
| 2008 FY | 293.26 Million EUR | 6.95% |
| 2007 FY | 274.2 Million EUR | -42.17% |
| 2006 FY | 474.14 Million EUR | 25.98% |
| 2005 FY | 376.37 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 316.48 Million EUR | -88.731% |
| Carl Zeiss Meditec AG | 1.2 Billion EUR | 50.462% |
| Fielmann Aktiengesellschaft | 576.41 Million EUR | -3.626% |
| Sartorius Aktiengesellschaft | 1.56 Billion EUR | 61.884% |
| Sartorius Aktiengesellschaft | 1.56 Billion EUR | 61.884% |